1Seron D.Early diagnosis of chronic allograft nephropathy by means of protocol biopsies[J].Transplant Proc, 2004, 36(3):763-764.
2Palaga T, Kataoka T, Nagai K, et al. Extracellular ATP inhibits apoptosis and maintains cell viability by inducing autocrine production of interleukin-4 in a myeloid progenitor cell line[J].Int Immunopharmacol, 2004, 4(7): 953-961.
3Groetzner J, Kaczmarek I, Landwehr P, et al.Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients[J].Eur J Cardiothoracic Surg, 2004, 25(3): 333-341.
4Ishimura T.Transforming growth factor-beta1 expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation[J].Clin Transplant, 2001,15(2): 185-191.
5Vazquez EM, Mosquera JM, Rivera CF,et al. Histological features with clinical impact in chronic allograft nephropathy: review of 66 cases[J].Transplant Proc, 2004, 36(3):770.
6Weir MR. Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation[J].Transplant Proc ,2001,33(1):19-28.
7Mele TS, Halloran PF.The use of mycophenolate mofetil in transplant recipients[J].Immunopharmacology,2000 ,47(2):215-245.
8Weir MR. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy[J].Kidney Int,2001, 59(7):1567-1573.
9Tsuzuki K. Role of mizoribine in renal transplantation[J].Pediatr Int,2002,44(1):224-231.
10Morales JM,Andres A, Rengel M,et al. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation[J]. Nephrol Dial Transplant,2001,16 (1): 121-124.
